Hudson flu specialist in the NHMRC spotlight
By Rob Clancy, staff writer. Reviewed by Associate Professor Michelle Tate
As Australia approaches another flu season, the nation’s peak medical research funding body has recognised a Hudson Institute researcher for her pioneering work on influenza.
Associate Professor Michelle Tate has been included in the National Health and Medical Research Council (NHMRC)’s latest edition of 10 of the Best.
A/Prof Tate is an international leader in the fields of viral pathogenesis and immunotherapies. She has made significant contributions to understanding the process by which viral infections cause disease and identifying new host-directed therapeutic targets and treatment strategies.
Her inclusion in the latest NHMRC list is under the heading Beyond the virus: discovering new treatments for influenza infections.
Hudson Institute respiratory research – not just for flu
Her research interests lie primarily in understanding the molecular mechanisms and host pathways involved in the development of hyperinflammation and severe disease, such as during an influenza A virus infection, as well incurable chronic respiratory diseases such as silicosis.
This research was supported by | NHMRC
Journal | Cell Death & Disease
Title | Gasdermin E deficiency limits inflammation and lung damage during influenza virus infection
View publication | https://www.nature.com/articles/s41419-025-07748-0
In this article
About Hudson Institute
Hudson Institute’ s research programs deliver in three areas of medical need – inflammation, cancer, women’s and newborn health. More
Hudson News
Get the inside view on discoveries and patient stories
“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”
